A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report

BACKGROUND: Immune thrombocytopenia is an acquired autoimmune disease. Recently, there has been evidence of thrombotic risk in patients with immune thrombocytopenia, but the mechanism is still inconclusive. Intravenous immunoglobulin infusion therapy is considered an efficient treatment; however, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Rungjirajittranon, Tarinee, Owattanapanich, Weerapat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348674/
https://www.ncbi.nlm.nih.gov/pubmed/30686269
http://dx.doi.org/10.1186/s13256-018-1955-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348674/
https://www.ncbi.nlm.nih.gov/pubmed/30686269
http://dx.doi.org/10.1186/s13256-018-1955-x

Ejemplares similares